GHA
IDXX icon

GW Henssler & Associates’s Idexx Laboratories IDXX Stock Holding History

GW Henssler & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Sell
30,424
-4,392
-13% -$2.46M 0.71% 58
2026
Q1 		$19.6M Buy
34,816
+1,079
+3% +$692K 0.92% 40
2025
Q4 		$22.8M Sell
33,737
-2,095
-6% -$1.43M 1.1% 29
2025
Q3 		$22.9M Sell
35,832
-559
-2% -$339K 1.14% 28
2025
Q2 		$19.5M Sell
36,391
-29
-0.1% -$13.9K 1.04% 38
2025
Q1 		$15.3M Buy
+36,420
New +$15.8M 0.88% 53

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GW Henssler & Associates's IDXX Position: Q2 2026 in Review

GW Henssler & Associates reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $2.46M and leaving 30,424 shares worth $16M. The position accounts for 0.71% of the portfolio, ranked #58.

GW Henssler & Associates first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $22.9M in Q3 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • GW Henssler & Associates held 30,424 shares of Idexx Laboratories worth $16M as of Q2 2026.
  • GW Henssler & Associates sold 4,392 Idexx Laboratories shares in Q2 2026, an estimated $2.46M.
  • Idexx Laboratories made up 0.71% of GW Henssler & Associates's portfolio in Q2 2026, its #58 holding.
  • GW Henssler & Associates first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • GW Henssler & Associates's Idexx Laboratories position peaked at $22.9M in Q3 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.